Two recipients to receive cutting-edge services from EA and Illumina to advance new applications in oncology research RESEARCH TRIANGLE PARK, NC – August 19, 2014 – Expression Analysis (EA), a Quintiles company, today announced that it is co-sponsoring a grant ...
Read More »Illumina adds products to support RNA-Seq on the newly launched NextSeq™ 500 sequencing system
Illumina Expands Product Portfolio to Support Oncology Clinical Research and Discovery End-to-End Genomics Solutions Will Transform the Future of Oncology SAN DIEGO–(BUSINESS WIRE)–Apr. 2, 2014– Illumina, Inc. (NASDAQ:ILMN) today announced new products that can be applied directly to the discovery ...
Read More »